Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Completed × hCG × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 107 Neoplasms 95 Polycystic Ovary Syndrome 58 Prostatic Neoplasms 52 Colorectal Neoplasms 45 Carcinoma, Non-Small-Cell Lung 39 Pain 36 Carcinoma, Hepatocellular 33 Lung Neoplasms 31 Precursor Cell Lymphoblastic Leukemia-Lymphoma 25 Keratosis, Actinic 25 Neoplasm Metastasis 23 Head and Neck Neoplasms 21 Stomach Neoplasms 20 Pain, Postoperative 20 Pancreatic Neoplasms 19 Multiple Myeloma 19 Colonic Neoplasms 19 Brain Neoplasms 19 Uterine Cervical Neoplasms 17 Lymphoma, Follicular 17 Leukemia 17 Anemia 17 Leukemia, Myeloid, Acute 16 Lymphoma 15 Infertility 15 Carcinoma, Renal Cell 15 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 14 Leiomyoma 14 Cancer Pain 14

Interventions

Chorionic Gonadotropin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03495609 2023-09-07

Use of Recombinant hCG to Prevent Breast Cancer in BRCA1 and BRCA2 Carriers

University Hospital, Ghent

Phase 4 Completed

hCG

Data powered by HemOnc (CC BY 4.0) Colophon ⚡